View Item 

Show simple item record

Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature
dc.contributor.authorAbdulfatah, Eman
dc.contributor.authorKennedy, John M
dc.contributor.authorHafez, Khaled
dc.contributor.authorDavenport, Matthew S
dc.contributor.authorXiao, Hong
dc.contributor.authorWeizer, Alon Z
dc.contributor.authorPalapattu, Ganesh S
dc.contributor.authorMorgan, Todd M
dc.contributor.authorMannan, Rahul
dc.contributor.authorWang, Xiao‐ming
dc.contributor.authorDhanasekaran, Saravana M
dc.contributor.authorKaffenberger, Samuel D
dc.contributor.authorSpratt, Daniel E
dc.contributor.authorKunju, Lakshmi
dc.contributor.authorWu, Angela
dc.contributor.authorLew, Madelyn
dc.contributor.authorUdager, Aaron M
dc.contributor.authorChinnaiyan, Arul M
dc.contributor.authorMehra, Rohit
dc.date.accessioned2020-06-03T15:24:06Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-06-03T15:24:06Z
dc.date.issued2020-05
dc.identifier.citationAbdulfatah, Eman; Kennedy, John M; Hafez, Khaled; Davenport, Matthew S; Xiao, Hong; Weizer, Alon Z; Palapattu, Ganesh S; Morgan, Todd M; Mannan, Rahul; Wang, Xiao‐ming ; Dhanasekaran, Saravana M; Kaffenberger, Samuel D; Spratt, Daniel E; Kunju, Lakshmi; Wu, Angela; Lew, Madelyn; Udager, Aaron M; Chinnaiyan, Arul M; Mehra, Rohit (2020). "Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature." Histopathology 76(6): 875-887.
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.urihttps://hdl.handle.net/2027.42/155536
dc.publisherWiley Periodicals, Inc.
dc.subject.otherclear cell renal cell carcinoma
dc.subject.otherhereditary leiomyomatosis and renal cell carcinoma syndrome
dc.subject.otherhereditary renal cell carcinoma
dc.subject.othersuccinate dehydrogenase deficiency
dc.subject.othertranslocation renal cell carcinoma
dc.subject.othertuberous sclerosis complex
dc.subject.otherVon Hippel- Lindau
dc.titleClinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155536/1/his14051.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155536/2/his14051_am.pdf
dc.identifier.doi10.1111/his.14051
dc.identifier.sourceHistopathology
dc.identifier.citedreferenceAltinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr. Dev. Pathol. 2005; 8; 168 - 180.
dc.identifier.citedreferenceEstrada CR, Suthar AM, Eaton SH, Cilento BG. Renal cell carcinoma: Children’s Hospital Boston experience. Urology 2005; 66; 1296 - 1300.
dc.identifier.citedreferenceLack EE, Cassady JR, Sallan SE. Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J. Urol. 1985; 133; 822 - 828.
dc.identifier.citedreferenceSuh JH, Oak T, Ro JY, Truong LD, Ayala AG, Shen SS. Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients. Int. J. Clin. Exp. Pathol. 2009; 2; 489 - 493.
dc.identifier.citedreferenceLopez- Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur. Urol. 2006; 49; 798 - 805.
dc.identifier.citedreferenceMoch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs- part A: renal, penile, and testicular tumours. Eur. Urol. 2016; 70; 93 - 105.
dc.identifier.citedreferenceLieber MM, Tomera FM, Taylor WF, Farrow GM. Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J. Urol. 1981; 125; 164 - 168.
dc.identifier.citedreferenceRainwater LM, Zincke H, Farrow GM, Gonchoroff NJ. Renal cell carcinoma in young and old patients. Comparison of prognostic pathologic variables (cell type, tumor grade and stage, and DNA ploidy pattern) and their impact on disease outcome. Urology 1991; 38; 1 - 5.
dc.identifier.citedreferenceMoudouni S, En- Nia I, Rioux- Leclerq N et al. Renal cell carcinoma before the age of 40: prognostic factors. Prog. Urol. 2002; 12; 575 - 578.
dc.identifier.citedreferenceSkala SL, Xiao H, Udager AM et al. Detection of 6 TFEB- amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod. Pathol. 2018; 31; 179 - 197.
dc.identifier.citedreferenceKennedy JM, Wang X, Plouffe KR et al. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series. Med. Oncol. 2019; 36; 74.
dc.identifier.citedreferenceArgani P. MiT family translocation renal cell carcinoma. Semin. Diagn. Pathol. 2015; 32; 103 - 113.
dc.identifier.citedreferenceGuo J, Tretiakova MS, Troxell ML et al. Tuberous sclerosis- associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am. J. Surg. Pathol. 2014; 38; 1457 - 1467.
dc.identifier.citedreferenceDelahunt B, Eble JN, Egevad L, Samaratunga H. Grading of renal cell carcinoma. Histopathology 2019; 74; 4 - 17.
dc.identifier.citedreferenceArgani P, Reuter VE, Zhang L et al. TFEB- amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity. Am. J. Surg. Pathol. 2016; 40; 1484 - 1495.
dc.identifier.citedreferenceTrpkov K, Hes O, Bonert M et al. Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women. Am. J. Surg. Pathol. 2016; 40; 60 - 71.
dc.identifier.citedreferenceTaccoen X, Valeri A, Descotes JL et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer- specific survival. Eur. Urol. 2007; 51; 980 - 987.
dc.identifier.citedreferenceBosquet M, Dominguez C, Balaguer J et al. Pediatric renal adenocarcinoma: a review of our series. Urology 2008; 72; 790 - 793.
dc.identifier.citedreferenceAbou El Fettouh HI, Cherullo EE, El- Jack M, Al Maslamani Y, Novick AC. Sporadic renal cell carcinoma in young adults: presentation, treatment, and outcome. Urology 2002; 60; 806 - 810.
dc.identifier.citedreferenceGillett MD, Cheville JC, Karnes RJ et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J. Urol. 2005; 173; 1893 - 1896.
dc.identifier.citedreferenceLopez JI, Moreno V, García H et al. Renal cell carcinoma in young adults: a study of 130 cases and a review of previous series. Urol. Int. 2010; 84; 292 - 300.
dc.identifier.citedreferenceArgani P, Olgac S, Tickoo SK et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 2007; 31; 1149 - 1160.
dc.identifier.citedreferenceMeyer PN, Clark JI, Flanigan RC. Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol. 2007; 128; 70 - 79.
dc.identifier.citedreferenceRamphal R, Pappo A, Zielenska M, Grant R. Ngan B- Y. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am. J. Clin. Pathol. 2006; 126; 349 - 364.
dc.identifier.citedreferenceAronson DC, Medary I, Finlay JL, Exelby PR, La Quaglia M. Renal cell carcinoma in childhood and adolescence: a retrospective survey for prognostic factors in 22 cases. J. Pediatr. Surg. 1996; 31; 183 - 186.
dc.identifier.citedreferenceXu L, Yang R, Gan W et al. Xp11.2 translocation renal cell carcinomas in young adults. BMC Urol. 2015; 15; 57.
dc.identifier.citedreferenceGeller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 2004; 101; 1575 - 1583.
dc.identifier.citedreferenceIndolfi P, Terenziani M, Casale F et al. Renal cell carcinoma in children: a clinicopathologic study. J. Clin. Oncol. 2003; 21; 530 - 535.
dc.identifier.citedreferenceBruder E, Passera O, Harms D et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004; 28; 1117 - 1132.
dc.identifier.citedreferenceSelle B, Furtwangler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population- based study of renal cell carcinoma in children in Germany, 1980- 2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer 2006; 107; 2906 - 2914.
dc.identifier.citedreferenceSchreiner A, Daneshmand S, Bayne A, Countryman G, Corless C, Troxell M. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int. J. Surg. Pathol. 2010; 18; 409 - 418.
dc.identifier.citedreferenceArgani P, Ladanyi M. The evolving story of renal translocation carcinomas. Am. J. Clin. Pathol. 2006; 126; 332 - 334.
dc.identifier.citedreferenceHuang FS, Zwerding T, Stern LE, Ballard ET, Warner BW. Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. J. Pediatr. Hematol. Oncol. 2001; 23; 609 - 611.
dc.identifier.citedreferenceArgani P, Lae M, Ballard ET et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J. Clin. Oncol. 2006; 24; 1529 - 1534.
dc.identifier.citedreferenceRais- Bahrami S, Drabick J, De Marzo A et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy- associated secondary malignancy. Urology 2007; 70 ( 178 ); e3 - e6.
dc.identifier.citedreferenceFalzarano SM, McKenney J, Montironi R et al. Renal cell carcinoma occurring in patients with prior neuroblastoma: a heterogenous group of neoplasms. Am. J. Surg. Pathol. 2016; 40; 989 - 997.
dc.identifier.citedreferenceLi Y, Reuter V, Matoso A, Netto G, Epstein J, Argani P. Re- evaluation of 33 - unclassified- eosinophilic renal cell carcinomas in young patients. Histopathology 2018; 72; 588 - 600.
dc.identifier.citedreferenceSkala SL, Dhanasekaran SM, Mehra R. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): a contemporary review and practical discussion of the differential diagnosis for HLRCC- associated renal cell carcinoma. Arch. Pathol. Lab. Med. 2018; 142; 1202 - 1215.
dc.identifier.citedreferenceInamura K. Translocation renal cell carcinoma: an update on clinicopathological and molecular features. Cancers 2017; 9; E111.
dc.identifier.citedreferenceLipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J. Urol. 2006; 176; 2353 - 2438.
dc.identifier.citedreferenceSilberstein J, Grabowski J, Saltzstein SL, Kane CJ. Renal cell carcinoma in the pediatric population: results from the California Cancer Registry. Pediatr. Blood Cancer 2009; 52; 237 - 2341.
dc.identifier.citedreferenceCarcao MD, Taylor GP, Greenberg ML et al. Renal- cell carcinoma in children: a different disorder from its adult counterpart? Med. Pediatr. Oncol. 1998; 31; 153 - 158.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
his14051.pdf
Size:
2.905MB
Format:
PDF
View/Open
Name:
his14051_am.pdf
Size:
493.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.